TreeWAS – Variant ID: rs10486023

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C67.9 Bladder, unspecified	0.126	0.874	0.000
C67 Malignant neoplasm of bladder	0.120	0.880	0.000
C67.2 Lateral wall of bladder	0.109	0.891	0.000
C67.4 Posterior wall of bladder	0.104	0.896	0.000
C67.5 Bladder neck	0.103	0.897	0.000
C67.8 Overlapping lesion of bladder	0.096	0.904	0.000
C67.0 Trigone of bladder	0.091	0.909	0.000
C67.1 Dome of bladder	0.088	0.912	0.000
C67.7 Urachus	0.086	0.914	0.000
C67.3 Anterior wall of bladder	0.085	0.915	0.000
C67.6 Ureteric orifice	0.069	0.930	0.000
C64-C68 Malignant neoplasms of urinary tract	0.063	0.937	0.000
C66 Malignant neoplasm of ureter	0.051	0.949	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.045	0.955	0.000
C65 Malignant neoplasm of renal pelvis	0.045	0.955	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.045	0.955	0.000
C68.9 Urinary organ, unspecified	0.033	0.967	0.000
C68.8 Overlapping lesion of urinary organs	0.033	0.967	0.000
C68.1 Paraurethral glands	0.033	0.967	0.000
C68.0 Urethra	0.033	0.967	0.000
N18.3 Chronic kidney disease, stage 3	0.032	0.968	0.000
N18 Chronic renal failure	0.030	0.970	0.000
N18.9 Chronic renal failure, unspecified	0.028	0.972	0.000
N17-N19 Renal failure	0.027	0.973	0.000
N19 Unspecified renal failure	0.026	0.974	0.000
N17 Acute renal failure	0.023	0.977	0.000
N18.8 Other chronic renal failure	0.023	0.977	0.000
N18.1 Chronic kidney disease, stage 1	0.022	0.978	0.000
N18.0 End-stage renal disease	0.022	0.978	0.000
N18.5 Chronic kidney disease, stage 5	0.021	0.978	0.000
N18.2 Chronic kidney disease, stage 2	0.021	0.979	0.000
N18.4 Chronic kidney disease, stage 4	0.020	0.980	0.000
N17.9 Acute renal failure, unspecified	0.020	0.980	0.000
N17.0 Acute renal failure with tubular necrosis	0.018	0.982	0.000
N17.8 Other acute renal failure	0.017	0.983	0.000
N17.2 Acute renal failure with medullary necrosis	0.017	0.983	0.000
N17.1 Acute renal failure with acute cortical necrosis	0.017	0.983	0.000
Z93.2 Ileostomy status	0.012	0.988	0.000
C34 Malignant neoplasm of bronchus and lung	0.012	0.988	0.000
C34.1 Upper lobe, bronchus or lung	0.011	0.989	0.000
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.011	0.989	0.000
C34.9 Bronchus or lung, unspecified	0.011	0.989	0.000
W19.4 Street and highway	0.011	0.989	0.000
Z93 Artificial opening status	0.010	0.990	0.000
C34.2 Middle lobe, bronchus or lung	0.010	0.990	0.000
Z93.3 Colostomy status	0.010	0.990	0.000
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts	0.009	0.991	0.000
Z93.4 Other artificial openings of gastro-intestinal tract status	0.009	0.991	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.009	0.991	0.000
Z93.6 Other artificial openings of urinary tract status	0.009	0.991	0.000
C34.3 Lower lobe, bronchus or lung	0.009	0.991	0.000
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.009	0.991	0.000
C34.0 Main bronchus	0.008	0.991	0.000
C34.8 Overlapping lesion of bronchus and lung	0.008	0.991	0.000
T82.1 Mechanical complication of cardiac electronic device	0.008	0.992	0.000
T82.3 Mechanical complication of other vascular grafts	0.008	0.992	0.000
T82.2 Mechanical complication of coronary artery bypass and valve grafts	0.008	0.992	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.008	0.992	0.000
C37 Malignant neoplasm of thymus	0.008	0.992	0.000
W19 Unspecified fall	0.008	0.992	0.000
Z93.9 Artificial opening status, unspecified	0.007	0.992	0.000
Z93.8 Other artificial opening status	0.007	0.992	0.000
Z93.1 Gastrostomy status	0.007	0.993	0.000
C30.0 Nasal cavity	0.007	0.993	0.000
T82.9 Unspecified complication of cardiac and vascular prosthetic device, implant and graft	0.007	0.993	0.000
T82.6 Infection and inflammatory reaction due to cardiac valve prosthesis	0.007	0.993	0.000
T82.4 Mechanical complication of vascular dialysis catheter	0.007	0.993	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.007	0.993	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.007	0.993	0.000
C32 Malignant neoplasm of larynx	0.007	0.993	0.000
C31 Malignant neoplasm of accessory sinuses	0.007	0.993	0.000
C33 Malignant neoplasm of trachea	0.007	0.993	0.000
T82.0 Mechanical complication of heart valve prosthesis	0.007	0.993	0.000
N81.2 Incomplete uterovaginal prolapse	0.007	0.993	0.000
W19.2 School, other institution and public administrative area	0.007	0.993	0.000
Z93.5 Cystostomy status	0.007	0.993	0.000
L60.0 Ingrowing nail	0.007	0.993	0.000
Z93.0 Tracheostomy status	0.006	0.994	0.000
C30.1 Middle ear	0.006	0.994	0.000
W19.8 Other specified place	0.006	0.994	0.000
W19.5 Trade and service area	0.006	0.994	0.000
W19.0 Home	0.006	0.994	0.000
W19.7 Farm	0.006	0.994	0.000
W19.6 Industrial and construction area	0.006	0.994	0.000
W19.1 Residential institution	0.006	0.994	0.000
T82.5 Mechanical complication of other cardiac and vascular devices and implants	0.006	0.994	0.000
W00-W19 Falls	0.006	0.994	0.000
W19.3 Sports and athletics area	0.006	0.994	0.000
C31.9 Accessory sinus, unspecified	0.005	0.995	0.000
C31.8 Overlapping lesion of accessory sinuses	0.005	0.995	0.000
C31.3 Sphenoidal sinus	0.005	0.995	0.000
C31.2 Frontal sinus	0.005	0.995	0.000
C31.1 Ethmoidal sinus	0.005	0.995	0.000
C31.0 Maxillary sinus	0.005	0.995	0.000
C32.9 Larynx, unspecified	0.005	0.995	0.000
C32.8 Overlapping lesion of larynx	0.005	0.995	0.000
C32.3 Laryngeal cartilage	0.005	0.995	0.000
C32.2 Subglottis	0.005	0.995	0.000
C32.1 Supraglottis	0.005	0.995	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.005	0.995	0.000
C38.4 Pleura	0.005	0.995	0.000
C38.3 Mediastinum, part unspecified	0.005	0.995	0.000
C38.2 Posterior mediastinum	0.005	0.995	0.000
C38.1 Anterior mediastinum	0.005	0.995	0.000
C38.0 Heart	0.005	0.995	0.000
C39.9 Ill-defined sites within the respiratory system	0.005	0.995	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.005	0.995	0.000
C39.0 Upper respiratory tract, part unspecified	0.005	0.995	0.000
L60 Nail disorders	0.005	0.995	0.000
C32.0 Glottis	0.005	0.995	0.000
L60.8 Other nail disorders	0.005	0.995	0.000
W08 Fall involving other furniture	0.005	0.995	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.005	0.995	0.000
W11 Fall on and from ladder	0.005	0.995	0.000
Chapter II Neoplasms	0.005	0.995	0.000
I51.7 Cardiomegaly	0.005	0.995	0.000
C09 Malignant neoplasm of tonsil	0.005	0.995	0.000
W08.0 Home	0.005	0.995	0.000
Z80.4 Family history of malignant neoplasm of genital organs	0.005	0.995	0.000
C09.9 Tonsil, unspecified	0.005	0.995	0.000
W19.9 Unspecified place	0.005	0.995	0.000
Z09.9 Follow-up examination after unspecified treatment for other conditions	0.005	0.995	0.000
W18 Other fall on same level	0.005	0.995	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.005	0.995	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.005	0.995	0.000
W19.09 Unspecified fall; Home; During unspecified activity	0.004	0.995	0.000
W19.08 Unspecified fall; Home; While engaged in other specified activities	0.004	0.995	0.000
W19.59 Unspecified fall; Trade and service area; During unspecified activity	0.004	0.995	0.000
W19.81 Unspecified fall; Other specified places; While engaged in leisure activity	0.004	0.995	0.000
C10 Malignant neoplasm of oropharynx	0.004	0.995	0.000
L60.2 Onychogryphosis	0.004	0.996	0.000
W17 Other fall from one level to another	0.004	0.996	0.000
W16 Diving or jumping into water causing injury other than drowning or submersion	0.004	0.996	0.000
W15 Fall from cliff	0.004	0.996	0.000
W14 Fall from tree	0.004	0.996	0.000
W12 Fall on and from scaffolding	0.004	0.996	0.000
W09 Fall involving playground equipment	0.004	0.996	0.000
W05 Fall involving wheelchair	0.004	0.996	0.000
W04 Fall while being carried or supported by other persons	0.004	0.996	0.000
W03 Other fall on same level due to collision with, or pushing by, another person	0.004	0.996	0.000
W01 Fall on same level from slipping, tripping and stumbling	0.004	0.996	0.000
W00 Fall on same level involving ice and snow	0.004	0.996	0.000
C97 Malignant neoplasms of independent (primary) multiple sites	0.004	0.996	0.000
W11.5 Trade and service area	0.004	0.996	0.000
Y84.8 Other medical procedures	0.004	0.996	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
W13 Fall from, out of or through building or structure	0.004	0.996	0.000
W10 Fall on and from stairs and steps	0.004	0.996	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
W07 Fall involving chair	0.004	0.996	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
W02 Fall involving ice-skates, skis, roller-skates or skateboards	0.004	0.996	0.000
C10.9 Oropharynx, unspecified	0.004	0.996	0.000
L60.5 Yellow nail syndrome	0.004	0.996	0.000
L60.4 Beau's lines	0.004	0.996	0.000
L60.3 Nail dystrophy	0.004	0.996	0.000
L60.1 Onycholysis	0.004	0.996	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.004	0.996	0.000
L60.9 Nail disorder, unspecified	0.004	0.996	0.000
C07 Malignant neoplasm of parotid gland	0.004	0.996	0.000
W18.3 Sports and athletics area	0.004	0.996	0.000
C44.5 Skin of trunk	0.000	0.996	0.004
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.004	0.996	0.000
W08.9 Unspecified place	0.004	0.996	0.000
W08.8 Other specified place	0.004	0.996	0.000
W08.7 Farm	0.004	0.996	0.000
W08.6 Industrial and construction area	0.004	0.996	0.000
W08.5 Trade and service area	0.004	0.996	0.000
W08.4 Street and highway	0.004	0.996	0.000
W08.3 Sports and athletics area	0.004	0.996	0.000
W08.2 School, other institution and public administrative area	0.004	0.996	0.000
W08.1 Residential institution	0.004	0.996	0.000
C01 Malignant neoplasm of base of tongue	0.004	0.996	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.004	0.996	0.000
C13 Malignant neoplasm of hypopharynx	0.004	0.996	0.000
C11 Malignant neoplasm of nasopharynx	0.004	0.996	0.000
C08 Malignant neoplasm of other and unspecified major salivary glands	0.004	0.996	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.004	0.996	0.000
C05 Malignant neoplasm of palate	0.004	0.996	0.000
C04 Malignant neoplasm of floor of mouth	0.004	0.996	0.000
C03 Malignant neoplasm of gum	0.004	0.996	0.000
C00 Malignant neoplasm of lip	0.004	0.996	0.000
C12 Malignant neoplasm of pyriform sinus	0.004	0.996	0.000
N32.9 Bladder disorder, unspecified	0.004	0.996	0.000
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.000	0.996	0.004
C02 Malignant neoplasm of other and unspecified parts of tongue	0.004	0.996	0.000
W11.9 Unspecified place	0.004	0.996	0.000
W11.8 Other specified place	0.004	0.996	0.000
W11.0 Home	0.004	0.996	0.000
W11.7 Farm	0.004	0.996	0.000
W11.6 Industrial and construction area	0.004	0.996	0.000
W11.4 Street and highway	0.004	0.996	0.000
W11.3 Sports and athletics area	0.004	0.996	0.000
W11.2 School, other institution and public administrative area	0.004	0.996	0.000
W11.1 Residential institution	0.004	0.996	0.000
Y57 Other and unspecified drugs and medicaments	0.004	0.996	0.000
C09.8 Overlapping lesion of tonsil	0.004	0.996	0.000
C09.1 Tonsillar pillar (anterior) (posterior)	0.004	0.996	0.000
C09.0 Tonsillar fossa	0.004	0.996	0.000
W06 Fall involving bed	0.003	0.996	0.000
Y54.5 Other diuretics	0.004	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
W18.9 Unspecified place	0.003	0.996	0.000
W18.8 Other specified place	0.003	0.996	0.000
W18.4 Street and highway	0.003	0.996	0.000
W18.2 School, other institution and public administrative area	0.003	0.996	0.000
W18.0 Home	0.003	0.996	0.000
W18.7 Farm	0.003	0.996	0.000
W18.6 Industrial and construction area	0.003	0.996	0.000
W18.1 Residential institution	0.003	0.996	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.003	0.996	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.003	0.996	0.000
C10.8 Overlapping lesion of oropharynx	0.003	0.996	0.000
C10.4 Branchial cleft	0.003	0.996	0.000
C10.3 Posterior wall of oropharynx	0.003	0.996	0.000
C10.2 Lateral wall of oropharynx	0.003	0.996	0.000
C10.1 Anterior surface of epiglottis	0.003	0.996	0.000
C10.0 Vallecula	0.003	0.996	0.000
Z04.8 Examination and observation for other specified reasons	0.003	0.996	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.003	0.996	0.000
W18.5 Trade and service area	0.003	0.997	0.000
Y42.5 Other oestrogens and progestogens	0.003	0.997	0.000
Chapter XX External causes of morbidity and mortality	0.003	0.997	0.000
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.003	0.997	0.000
W00.9 Unspecified place	0.003	0.997	0.000
W00.8 Other specified place	0.003	0.997	0.000
W00.4 Street and highway	0.003	0.997	0.000
W00.0 Home	0.003	0.997	0.000
W00.7 Farm	0.003	0.997	0.000
W00.6 Industrial and construction area	0.003	0.997	0.000
W00.5 Trade and service area	0.003	0.997	0.000
W00.3 Sports and athletics area	0.003	0.997	0.000
W00.2 School, other institution and public administrative area	0.003	0.997	0.000
W00.1 Residential institution	0.003	0.997	0.000
W01.9 Unspecified place	0.003	0.997	0.000
W01.8 Other specified place	0.003	0.997	0.000
W01.5 Trade and service area	0.003	0.997	0.000
W01.4 Street and highway	0.003	0.997	0.000
W01.3 Sports and athletics area	0.003	0.997	0.000
W01.2 School, other institution and public administrative area	0.003	0.997	0.000
W01.0 Home	0.003	0.997	0.000
W01.7 Farm	0.003	0.997	0.000
W01.6 Industrial and construction area	0.003	0.997	0.000
W01.1 Residential institution	0.003	0.997	0.000
W03.8 Other specified place	0.003	0.997	0.000
W03.3 Sports and athletics area	0.003	0.997	0.000
W03.9 Unspecified place	0.003	0.997	0.000
W03.7 Farm	0.003	0.997	0.000
W03.6 Industrial and construction area	0.003	0.997	0.000
W03.5 Trade and service area	0.003	0.997	0.000
W03.4 Street and highway	0.003	0.997	0.000
W03.2 School, other institution and public administrative area	0.003	0.997	0.000
W03.1 Residential institution	0.003	0.997	0.000
W03.0 Home	0.003	0.997	0.000
W04.9 Unspecified place	0.003	0.997	0.000
W04.8 Other specified place	0.003	0.997	0.000
W04.7 Farm	0.003	0.997	0.000
W04.6 Industrial and construction area	0.003	0.997	0.000
W04.5 Trade and service area	0.003	0.997	0.000
W04.4 Street and highway	0.003	0.997	0.000
W04.3 Sports and athletics area	0.003	0.997	0.000
W04.2 School, other institution and public administrative area	0.003	0.997	0.000
W04.1 Residential institution	0.003	0.997	0.000
W04.0 Home	0.003	0.997	0.000
W05.9 Unspecified place	0.003	0.997	0.000
W05.8 Other specified place	0.003	0.997	0.000
W05.7 Farm	0.003	0.997	0.000
W05.6 Industrial and construction area	0.003	0.997	0.000
W05.5 Trade and service area	0.003	0.997	0.000
W05.4 Street and highway	0.003	0.997	0.000
W05.3 Sports and athletics area	0.003	0.997	0.000
W05.2 School, other institution and public administrative area	0.003	0.997	0.000
W05.1 Residential institution	0.003	0.997	0.000
W05.0 Home	0.003	0.997	0.000
W09.9 Unspecified place	0.003	0.997	0.000
W09.8 Other specified place	0.003	0.997	0.000
W09.7 Farm	0.003	0.997	0.000
W09.6 Industrial and construction area	0.003	0.997	0.000
W09.5 Trade and service area	0.003	0.997	0.000
W09.4 Street and highway	0.003	0.997	0.000
W09.3 Sports and athletics area	0.003	0.997	0.000
W09.2 School, other institution and public administrative area	0.003	0.997	0.000
W09.1 Residential institution	0.003	0.997	0.000
W09.0 Home	0.003	0.997	0.000
W12.9 Unspecified place	0.003	0.997	0.000
W12.6 Industrial and construction area	0.003	0.997	0.000
W12.8 Other specified place	0.003	0.997	0.000
W12.7 Farm	0.003	0.997	0.000
W12.5 Trade and service area	0.003	0.997	0.000
W12.4 Street and highway	0.003	0.997	0.000
W12.3 Sports and athletics area	0.003	0.997	0.000
W12.2 School, other institution and public administrative area	0.003	0.997	0.000
W12.1 Residential institution	0.003	0.997	0.000
W12.0 Home	0.003	0.997	0.000
W14.9 Unspecified place	0.003	0.997	0.000
W14.8 Other specified place	0.003	0.997	0.000
W14.7 Farm	0.003	0.997	0.000
W14.6 Industrial and construction area	0.003	0.997	0.000
W14.5 Trade and service area	0.003	0.997	0.000
W14.4 Street and highway	0.003	0.997	0.000
W14.3 Sports and athletics area	0.003	0.997	0.000
W14.2 School, other institution and public administrative area	0.003	0.997	0.000
W14.1 Residential institution	0.003	0.997	0.000
W14.0 Home	0.003	0.997	0.000
W15.9 Unspecified place	0.003	0.997	0.000
W15.8 Other specified place	0.003	0.997	0.000
W15.7 Farm	0.003	0.997	0.000
W15.6 Industrial and construction area	0.003	0.997	0.000
W15.5 Trade and service area	0.003	0.997	0.000
W15.4 Street and highway	0.003	0.997	0.000
W15.3 Sports and athletics area	0.003	0.997	0.000
W15.2 School, other institution and public administrative area	0.003	0.997	0.000
W15.1 Residential institution	0.003	0.997	0.000
W15.0 Home	0.003	0.997	0.000
W16.9 Unspecified place	0.003	0.997	0.000
W16.8 Other specified place	0.003	0.997	0.000
W16.7 Farm	0.003	0.997	0.000
W16.6 Industrial and construction area	0.003	0.997	0.000
W16.5 Trade and service area	0.003	0.997	0.000
W16.4 Street and highway	0.003	0.997	0.000
W16.3 Sports and athletics area	0.003	0.997	0.000
W16.2 School, other institution and public administrative area	0.003	0.997	0.000
W16.1 Residential institution	0.003	0.997	0.000
W16.0 Home	0.003	0.997	0.000
W17.9 Unspecified place	0.003	0.997	0.000
W17.8 Other specified place	0.003	0.997	0.000
W17.0 Home	0.003	0.997	0.000
W17.7 Farm	0.003	0.997	0.000
W17.6 Industrial and construction area	0.003	0.997	0.000
W17.5 Trade and service area	0.003	0.997	0.000
W17.4 Street and highway	0.003	0.997	0.000
W17.3 Sports and athletics area	0.003	0.997	0.000
W17.2 School, other institution and public administrative area	0.003	0.997	0.000
W17.1 Residential institution	0.003	0.997	0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.003	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
K81.9 Cholecystitis, unspecified	0.003	0.997	0.000
D41.4 Bladder	0.003	0.997	0.000
W07.9 Unspecified place	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
D00-D09 In situ neoplasms	0.003	0.997	0.000
W10.9 Unspecified place	0.003	0.997	0.000
W10.5 Trade and service area	0.003	0.997	0.000
W10.2 School, other institution and public administrative area	0.003	0.997	0.000
W10.0 Home	0.003	0.997	0.000
W10.7 Farm	0.003	0.997	0.000
W10.6 Industrial and construction area	0.003	0.997	0.000
W10.4 Street and highway	0.003	0.997	0.000
W10.3 Sports and athletics area	0.003	0.997	0.000
W10.1 Residential institution	0.003	0.997	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.003	0.997	0.000
W13.8 Other specified place	0.003	0.997	0.000
W13.0 Home	0.003	0.997	0.000
W13.7 Farm	0.003	0.997	0.000
W13.6 Industrial and construction area	0.003	0.997	0.000
W13.5 Trade and service area	0.003	0.997	0.000
W13.4 Street and highway	0.003	0.997	0.000
W13.3 Sports and athletics area	0.003	0.997	0.000
W13.2 School, other institution and public administrative area	0.003	0.997	0.000
W13.1 Residential institution	0.003	0.997	0.000
Y54.3 Benzothiadiazine derivatives	0.003	0.997	0.000
Y42.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
Y42.4 Oral contraceptives	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
W07.2 School, other institution and public administrative area	0.003	0.997	0.000
W07.8 Other specified place	0.003	0.997	0.000
W07.7 Farm	0.003	0.997	0.000
W07.6 Industrial and construction area	0.003	0.997	0.000
W07.5 Trade and service area	0.003	0.997	0.000
W07.4 Street and highway	0.003	0.997	0.000
W07.3 Sports and athletics area	0.003	0.997	0.000
W07.1 Residential institution	0.003	0.997	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.003	0.997	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
Y51.0 Anticholinesterase agents	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
J03.9 Acute tonsillitis, unspecified	0.000	0.997	0.003
W02.8 Other specified place	0.003	0.997	0.000
W02.3 Sports and athletics area	0.003	0.997	0.000
W02.7 Farm	0.003	0.997	0.000
W02.6 Industrial and construction area	0.003	0.997	0.000
W02.5 Trade and service area	0.003	0.997	0.000
W02.4 Street and highway	0.003	0.997	0.000
W02.2 School, other institution and public administrative area	0.003	0.997	0.000
W02.1 Residential institution	0.003	0.997	0.000
W02.0 Home	0.003	0.997	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
Y57.8 Other drugs and medicaments	0.003	0.997	0.000
Y57.5 X-ray contrast media	0.003	0.997	0.000
D04 Carcinoma in situ of skin	0.003	0.997	0.000
D41.0 Kidney	0.003	0.997	0.000
Y84.1 Kidney dialysis	0.003	0.997	0.000
C50-C50 Malignant neoplasm of breast	0.003	0.997	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.003	0.997	0.000
V40-V49 Car occupant injured in transport accident	0.003	0.997	0.000
W10.8 Other specified place	0.003	0.997	0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.003	0.997	0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.003	0.997	0.000
W13.9 Unspecified place	0.003	0.997	0.000
C51-C58 Malignant neoplasms of female genital organs	0.003	0.997	0.000
C60-C63 Malignant neoplasms of male genital organs	0.003	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.997	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.997	0.000
Y54.7 Agents affecting calcification	0.003	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.997	0.000
Y54.0 Mineralocorticoids	0.003	0.997	0.000
C00.9 Lip, unspecified	0.003	0.997	0.000
C00.8 Overlapping lesion of lip	0.003	0.997	0.000
C00.6 Commissure of lip	0.003	0.997	0.000
C00.5 Lip, unspecified, inner aspect	0.003	0.997	0.000
C00.4 Lower lip, inner aspect	0.003	0.997	0.000
C00.3 Upper lip, inner aspect	0.003	0.997	0.000
C00.2 External lip, unspecified	0.003	0.997	0.000
C00.1 External lower lip	0.003	0.997	0.000
C00.0 External upper lip	0.003	0.997	0.000
C03.9 Gum, unspecified	0.003	0.997	0.000
C03.1 Lower gum	0.003	0.997	0.000
C03.0 Upper gum	0.003	0.997	0.000
C04.9 Floor of mouth, unspecified	0.003	0.997	0.000
C04.8 Overlapping lesion of floor of mouth	0.003	0.997	0.000
C04.1 Lateral floor of mouth	0.003	0.997	0.000
C04.0 Anterior floor of mouth	0.003	0.997	0.000
C05.9 Palate, unspecified	0.003	0.997	0.000
C05.8 Overlapping lesion of palate	0.003	0.997	0.000
C05.2 Uvula	0.003	0.997	0.000
C05.1 Soft palate	0.003	0.997	0.000
C05.0 Hard palate	0.003	0.997	0.000
C06.9 Mouth, unspecified	0.003	0.997	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.003	0.997	0.000
C06.2 Retromolar area	0.003	0.997	0.000
C06.1 Vestibule of mouth	0.003	0.997	0.000
C06.0 Cheek mucosa	0.003	0.997	0.000
C08.9 Major salivary gland, unspecified	0.003	0.997	0.000
C08.8 Overlapping lesion of major salivary glands	0.003	0.997	0.000
C08.1 Sublingual gland	0.003	0.997	0.000
C08.0 Submandibular gland	0.003	0.997	0.000
C11.9 Nasopharynx, unspecified	0.003	0.997	0.000
C11.8 Overlapping lesion of nasopharynx	0.003	0.997	0.000
C11.3 Anterior wall of nasopharynx	0.003	0.997	0.000
C11.2 Lateral wall of nasopharynx	0.003	0.997	0.000
C11.1 Posterior wall of nasopharynx	0.003	0.997	0.000
C11.0 Superior wall of nasopharynx	0.003	0.997	0.000
C13.9 Hypopharynx, unspecified	0.003	0.997	0.000
C13.8 Overlapping lesion of hypopharynx	0.003	0.997	0.000
C13.2 Posterior wall of hypopharynx	0.003	0.997	0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.003	0.997	0.000
C13.0 Postcricoid region	0.003	0.997	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.003	0.997	0.000
C14.2 Waldeyer's ring	0.003	0.997	0.000
C14.0 Pharynx, unspecified	0.003	0.997	0.000
Y84.2 Radiological procedure and radiotherapy	0.003	0.997	0.000
C02.8 Overlapping lesion of tongue	0.003	0.997	0.000
C02.4 Lingual tonsil	0.003	0.997	0.000
C02.3 Anterior two-thirds of tongue, part unspecified	0.003	0.997	0.000
C02.2 Ventral surface of tongue	0.003	0.997	0.000
C02.1 Border of tongue	0.003	0.997	0.000
C02.0 Dorsal surface of tongue	0.003	0.997	0.000
D04.5 Skin of trunk	0.003	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.003	0.997	0.000
W11.09 Fall on and from ladder; Home; During unspecified activity	0.003	0.997	0.000
W11.03 Fall on and from ladder; Home; While engaged in other types of work	0.003	0.997	0.000
W11.82 Fall on and from ladder; Other specified places; While working for income	0.003	0.997	0.000
W11.99 Fall on and from ladder; Unspecified place; During unspecified activity	0.003	0.997	0.000
W02.9 Unspecified place	0.003	0.997	0.000
W07.0 Home	0.003	0.997	0.000
C41.1 Mandible	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.6 Other diagnostic agents	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
C02.9 Tongue, unspecified	0.003	0.997	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.003	0.997	0.000
D04.7 Skin of lower limb, including hip	0.003	0.997	0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
Y43 Primarily systemic agents	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations